Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
chronic kidney disease
3
×
clinical trials
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
3
×
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biofourmis
cancer
cancer immunotherapy
europe blog main
europe top stories
glaxosmithkline
ipo
medical devices
sanofi
What
bio
companies
life
roundup
science
therapeutics
week
abbvie’s
ahead
biofourmis
biotechs
black
bucks
cancer
celebrate
chance
club
continue
continued
corner
crop
day
days
debut
diamond
diamond’s
exceeded
firms
forward
group
haul
holiday
indication
ipo
joined
labor
latest
leading
looking
mammoth
Language
unset
Current search:
fda
×
" texas blog main "
×
" chronic kidney disease "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M